Summaries for patients. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults.
D000273:Adipose Tissue / Q000187:drug effects; D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000378:metabolism; D001823:Body Composition / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D019382:Human Growth Hormone / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D007328:Insulin / Q000097:blood; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000097:blood / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000033:anatomy & histology; D013141:Spiro Compounds / Q000008:administration & dosage*; D013848:Thigh
D001786:Blood Glucose; D007211:Indoles; D007328:Insulin; D018970:Insulin-Like Growth Factor Binding Protein 1; D013141:Spiro Compounds; D019382:Human Growth Hormone; C094817:ibutamoren mesylate